Pregabalin Capsule
Product Images NDC 46708-124

Product Visual Gallery

This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 46708-124). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30 Capsules (Pregabalin 100mg)

Each capsule contains 100 mg of pregabalin USP. Store the medication at 25°C (77°F), with excursions allowed up to 15-30°C (59-86°F) as per USP Controlled Room Temperature guidelines. Dosage and use information is available in the accompanying prescribing information, and the medication comes in 30 capsules per package (Rx only). Manufactured by Alembic Pharmaceuticals Limited Formulation Division, the medication is dispensed in light containers (USP) and comes with a separate guide for each patient. The Lot number for this specific package is 610250.*

FDA Label Image

30 Capsules (Pregabalin 150mg)

Each capsule contains 150 mg of pregabalin USP. This medication is prescription-only, and dosing instructions should be followed carefully. The medication should be stored at a temperature of 25°C (77°F), with permitted excursions to 15-30°C (59-86°F), as specified under USP Controlled Room Temperature guidelines. The medication is produced by Alembic Pharmaceuticals Limited (Formulation Division) in India, and comes in a package of 30 capsules with an NDC code of 46708-123-30. Pharmacists are advised to dispense a medication guide to each patient separately, and the medication should be dispensed in properly labeled containers. The lot number of the medication is BXP, and the facility has been assigned the licensing number GI959.*

FDA Label Image

30 Capsules (Pregabalin 200mg)

Each capsule contains 200 mg pregabalin USP. This medication is manufactured by Alembic Pharmaceuticals Limited in India, and is available in 30 capsule containers. The recommended dosage and usage guidelines can be found in the accompanying prescribing information. It should be stored at 25°C (17°F) with excursions permitted to 15-30°C (59-86°F). Pharmacists are advised to dispense the medication guide provided separately to each patient.*

FDA Label Image

30 Capsules (Pregabalin 225mg)

Each capsule contains 25mg of Pregabalin USP. The dosage and usage instructions are available in the accompanying prescription information. It is recommended to store the capsules at a controlled room temperature of 25°C (17°F), with permitted excursions between 15-30°C (59-86°F) as per the USP standards. The medication should be dispensed in the USP-approved light containers. The manufacturer is Alembic Pharmaceuticals Limited, based in Gujarat, India. The product is packaged in a container consisting of 30 capsules with an NDC number of 46708-125-30. It is important that pharmacists dispense the medication guide that is separately provided to each patient. The Lot and EXP details are not available.*

FDA Label Image

30 Capsules (Pregabalin 25mg)

This is a medication called Pregabalin in capsule form. Each capsule has 25 mg of Pregabalin USP. The recommended dosage and usage information is not available and should be obtained from the accompanying prescribing information. It should be stored at a temperature of 25°C (77°F) with excursions allowed between 15-30°C (59-86°F), in accordance with USP Controlled Room Temperature guidelines. It is manufactured by Aembic Pharmaceuticals Limited's Formulation Division, located in Village Panelay, P.O. Tajpura, near Baska, Taiuka-Halol Panchmahal, 389350, Gujarat, India. It comes in an ight container (USP) and should be dispensed along with the Medication Guide provided separately to each patient. The Lot number is not available.*

FDA Label Image

30 Capsules (Pregabalin 300mg)

Each capsule contains 300 mg pregabalin USP. For dosage and use, refer to accompanying prescribing information. Store between 15-30°C. Dispense in ight containers. Manufactured by Alembic Pharmaceuticals Limited in Gujarat, India. The product is pregabalin capsules with a strength of 300mg. Pharmacist should dispense medication guides separately to each patient. Rx only with lot number and expiration date.*

FDA Label Image

30 Capsules (Pregabalin 50mg)

Each capsule contains 50 mg of pregabalin USP. This medication should be used as directed by a prescribing professional. It must be stored between 15-30°C (59-86°F). Alembic Pharmaceuticals Limited, the formulation division, manufactures the Pregabalin Capsules. The medication guide should be provided separately to each patient. This is a prescription drug available in packs of 30 capsules. Lot number unavailable.*

FDA Label Image

30 Capsules (Pregabalin 75mg)

Each capsule contains 75 mg Pregabalin USP used for the treatment of nerve pain, fibromyalgia, epilepsy, and generalized anxiety disorder. Refer to the accompanying prescribing information for dosage and usage. Store it at controlled room temperature as per the instructions. Manufactured by Alembic Pharmaceuticals Limited in India, these capsules are available in a pack of 30 and come with medication guides. Pharmacists must dispense it in air-tight containers. The lot number is not available in the text.*

FDA Label Image

Pregabalin-equation (Pregabalin Equation)

FDA Label Image

Figure 10 (Pregabalin Fig10)

The text appears to be a graph that shows the estimated percentage of subjects without LTR (likely to relapse) over time for pregabalin and a placebo. The x-axis represents the number of days, and the y-axis represents the percentage of subjects without LTR. It appears that pregabalin has a higher success rate in preventing LTR than the placebo.*

FDA Label Image

Figure 11 (Pregabalin Fig11)

FDA Label Image

Figure 12 (Pregabalin Fig12)

FDA Label Image

Figure 3 (Pregabalin Fig3)

This is a table showing the percent improvement in pain from baseline for patients taking different doses of Pregabalin (300mg, 150mg, 75mg) and placebo, measured as a score from 0 to 300. The percentage of patients with improved pain is shown on the y-axis, and the doses are shown on the x-axis.*

FDA Label Image

Figure 4 (Pregabalin Fig4)

This is a graph displaying the percentage of patients who improved in pain from baseline after taking Pregabalin 200 mg three times a day, Pregabalin 100 mg three times a day, and placebo. The horizontal axis represents the percentage improvement in pain, while the vertical axis displays the number of patients.*

FDA Label Image

Figure 5 (Pregabalin Fig5)

This appears to be a chart or graph showing the percent of patients who saw pain improvement from baseline while taking either Pregabalin 100 mg three times a day, Pregabalin 50 mg three times a day, or a placebo. Unfortunately, without more context or a clearer image, it's difficult to provide a more detailed description.*

FDA Label Image

Figure 6 (Pregabalin Fig6)

This text provides information on the responder rate (%) for two studies (E1 and E3) related to some treatment. The responder rate was 60% for Study E1, but the rate for Study E3 is not clear, as the text contains some unreadable characters. However, the data suggest that the responder rate for Study E3 was statistically significant compared to a placebo group.*

FDA Label Image

Figure 7 (Pregabalin Fig7)

FDA Label Image

Figure 9 (Pregabalin Fig9)

The text shows a comparison of the percent of patients improved in pain based on the dosage of pregabalin and placebo. It shows that the patients who took pregabalin in a daily dose of 600mg and 450mg had the highest percentage of improvement in pain, while patients who took a daily dose of 300mg and placebo had 0% improvement in pain. The graph also shows the percentage of improvement in pain from baseline for different doses of pregabalin and placebo.*

FDA Label Image

Figure 1 (Pregabalin Figure1)

FDA Label Image

Figure 2 (Pregabalin Figure2)

This is a medical data table that includes the percent of patients improved with Pregabalin 100 mg three times a day compared to Placebo. The percent of improvement in pain from baseline is also provided on the table.*

FDA Label Image

Structure (Pregabalin Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.